Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population‐based study

Abstract

In this nationwide population-based study of patients with CHB, statin use was consistently associated with a significant and dose-dependent reduction in HCC risk. In contrast, the association between aspirin use and HCC risk reduction was not dose-dependent and was suggested to be confounded by statins.